RAE-1 Family of Proteins in Innate and Adaptive Immunity
RAE-1 Family of Proteins in Innate and Adaptive Immunity
批准号:
7176918
负责人:
LEWIS Lee LANIER
金额:
$28.77万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-02-14 至 2009-01-31
关键词:
AdultAffectAffinityAllogenicAllograftingAnti-Bacterial AgentsAntigensAutoimmune DiseasesCD8B1 geneCell physiologyCellsChronicCytomegalovirusCytotoxic T-LymphocytesExposure toFamilyGene FamilyGenesGlycoproteinsHistocompatibility Antigens Class IHumanImmune responseImmunityImmunologic ReceptorsMHC Class I GenesMediatingModelingMusMyeloid CellsNatural Killer CellsNormal CellOncogenic VirusesOrthologous GeneProtein BindingProtein FamilyProteinsRoleStimulusStressT-LymphocyteViral ProteinsVirusVirus Diseaseskillingsmacrophagemicrobialpathogenprogramsreceptorresponsetumor
中文摘要
自然杀伤(NK)细胞参与针对病原体和肿瘤的先天免疫反应。的确有
越来越多的证据表明,它们与同种异体移植排斥反应有关,可能还与某些自身免疫性疾病有关。
NK细胞上负责激活它们的受体直到现在才被认识到。这其中的一个
NKG2D受体与NK细胞杀死某些肿瘤和病毒感染的能力有关
细胞。NKG2D表达于所有NK细胞、CDS+T细胞、Y6-TCR+T细胞和部分活化的巨噬细胞。
最近,我们和其他人克隆了一个小鼠基因家族,命名为RAE-1,编码类MHC I
与小鼠NKG2D高亲和力结合的蛋白质。人类RAE-1基因的同源基因(指定为
ULBP或RAE-L样基因)已被鉴定,这些基因编码的蛋白质是
由人类NKG2D受体识别。在人类中,NKG2D受体也识别MICA和
MICB,由应激、转化和病毒感染诱导的多态MHC I类抗原。
新的证据表明,RAE-1和MIC糖蛋白可能有助于触发先天免疫
NK细胞和Ys-TCR+T细胞介导的应答及其共刺激抗原特异性应答的功能
由CD8+细胞毒T淋巴细胞介导。我们建议研究RAE-I基因家族并确定它们的
在先天免疫和获得性免疫反应中的作用。该计划的具体目标是:1)确定是否
RAE-1基因是多态的,分析它们的表达并确定它们是否引发同种异体反应,
2)建立病毒感染期间RAE-1分子诱导的相关性,以确定如何
人CMV UL 16蛋白和潜在的其他病毒蛋白干扰RAE-1,并评估是否
HCMV以外的病毒诱导RAE-1基因,以及3)评估导致
正常细胞中RAE-1基因的诱导。本项目的总体目标是了解
RAE-1家族抗原在先天免疫和获得性免疫中的有利和潜在不利作用
回应。
英文摘要
Natural killer (NK) cells participate in the innate immune response against pathogens and tumors. There is
growing evidence that they are involved in allograft rejection and possibly in certain autoimmune diseases.
The receptors on NK cells responsible for their activation are only now being appreciated. One of these
receptors, NKG2D has been implicated in the ability of NK cells to kill certain tumors and virus-infected
cells. NKG2D is present on all NK cells, CDS+T cells, y6-TcR + T cells and some activated macrophages.
Recently, we and others cloned a family of mouse genes, designated RAE-1, encoding MHC class I-like
proteins that bind with high affinity to mouse NKG2D. Human orthologs of the RAE-1 genes (designated as
either ULBP or RAE-l-like genes) have been identified and the proteins encoded by these genes are
recognized by the human NKG2D receptor. In humans, the NKG2D receptor also recognizes MICA and
MICB, polymorphic MHC class I antigens that are induced by stress, transformation and viral infection.
Emerging evidence suggests that the RAE-1 and MIC glycoproteins may serve to trigger the innate immune
responses mediated by NK cells and yS-TcR +T cells and function to co-stimulate antigen-specific responses
by CD8 + cytotoxic T lymphocytes. We propose to investigate the RAE-I family of genes and determine their
role in innate and adaptive immune responses. The specific aims of this program are: 1) to determine whether
the RAE-1 genes are polymorphic, analyze their expression and determine if they elicit allogeneic responses,
2) to establish the relevance of induction of the RAE-1 molecules during viral infection, to determine how the
human CMV UL 16 protein and potentially other viral proteins interfere with RAE-1, and to evaluate whether
viruses other than HCMV induce the RAE-1 genes, and 3) to evaluate the mechanisms responsible for the
induction of the RAE-1 genes in normal cells. The overall objective of this project is to understand both the
beneficial and potentially adverse functions of the RAE- 1 family of antigens in innate and adaptive immune
responses.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Project 2: Natural Killer Cell Response to Cytomegalovirus Infection in Renal Transplantation
-
批准号:10000882
-
项目类别:
-
资助金额:$25.09万
-
财政年份:2017
-
负责人:LEWIS Lee LANIER
-
依托单位:
Project 2: Natural Killer Cell Response to Cytomegalovirus Infection in Renal Transplantation
-
批准号:10225364
-
项目类别:
-
资助金额:$27.89万
-
财政年份:2017
-
负责人:LEWIS Lee LANIER
-
依托单位:
UCSF DVS CyTOF Mass Cytometer
-
批准号:8639996
-
项目类别:
-
资助金额:$60.0万
-
财政年份:2014
-
负责人:LEWIS Lee LANIER
-
依托单位:
13th International Meeting of the Society for Natural Immunity April 20-24, 2012
-
批准号:8254058
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2012
-
负责人:LEWIS Lee LANIER
-
依托单位:
KIR and the Role of CD8 in NK Cell Function
-
批准号:6915448
-
项目类别:
-
资助金额:$11.85万
-
财政年份:2005
-
负责人:LEWIS Lee LANIER
-
依托单位:
NK Cell Biology
-
批准号:8433487
-
项目类别:
-
资助金额:$27.14万
-
财政年份:2003
-
负责人:LEWIS Lee LANIER
-
依托单位:
NK Cell Biology
-
批准号:7742636
-
项目类别:
-
资助金额:$29.81万
-
财政年份:2003
-
负责人:LEWIS Lee LANIER
-
依托单位:
NK Cell Biology
-
批准号:7579473
-
项目类别:
-
资助金额:$29.82万
-
财政年份:2003
-
负责人:LEWIS Lee LANIER
-
依托单位:
RAE-1 Family of Proteins in Innate and Adaptive Immunity
-
批准号:6580157
-
项目类别:
-
资助金额:$26.88万
-
财政年份:2003
-
负责人:LEWIS Lee LANIER
-
依托单位:
RAE-1 Family of Proteins in Innate and Adaptive Immunity
-
批准号:7012762
-
项目类别:
-
资助金额:$29.62万
-
财政年份:2003
-
负责人:LEWIS Lee LANIER
-
依托单位:
RAE-1 Family of Proteins in Innate and Adaptive Immunity
-
批准号:6839417
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2003
-
负责人:LEWIS Lee LANIER
-
依托单位:
RAE-1 Family of Proteins in Innate and Adaptive Immunity
-
批准号:6704768
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2003
-
负责人:LEWIS Lee LANIER
-
依托单位:
NK Cell Biology
-
批准号:8209107
-
项目类别:
-
资助金额:$28.89万
-
财政年份:2003
-
负责人:LEWIS Lee LANIER
-
依托单位:
NK Cell Biology
-
批准号:8016084
-
项目类别:
-
资助金额:$28.9万
-
财政年份:2003
-
负责人:LEWIS Lee LANIER
-
依托单位:
Biology of Leukocyte Regulatory Receptor
-
批准号:6439858
-
项目类别:
-
资助金额:$0.2万
-
财政年份:2002
-
负责人:LEWIS Lee LANIER
-
依托单位:
NK and T Cell Costimulation by NKG2D/DAP10
-
批准号:6967562
-
项目类别:
-
资助金额:$37.72万
-
财政年份:2001
-
负责人:LEWIS Lee LANIER
-
依托单位:
NK AND T CELL COSTIMULATION BY NKG2D/DAP10
-
批准号:6498047
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2001
-
负责人:LEWIS Lee LANIER
-
依托单位:
NK CELL RECEPTORS AND THEIR LIGANDS
-
批准号:6489409
-
项目类别:
-
资助金额:$31.16万
-
财政年份:2001
-
负责人:LEWIS Lee LANIER
-
依托单位:
NK AND T CELL COSTIMULATION BY NKG2D/DAP10
-
批准号:6628494
-
项目类别:
-
资助金额:$28.04万
-
财政年份:2001
-
负责人:LEWIS Lee LANIER
-
依托单位:
NK Cell Receptors and Their Ligands
-
批准号:7340777
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2001
-
负责人:LEWIS Lee LANIER
-
依托单位:
海外基金